Spruce Biosciences, Inc.
SPRB
$52.64
$2.875.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -685.15% | 12.64% | 37.83% | 5.29% | 77.49% |
| Total Depreciation and Amortization | 8,914.29% | 4,100.00% | -44.44% | -70.00% | -41.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 169.49% | 88.69% | 463.71% | -51.33% | -127.00% |
| Change in Net Operating Assets | -8.80% | 183.66% | 30.25% | 230.84% | -70.85% |
| Cash from Operations | -150.57% | 31.39% | 68.78% | 42.36% | 20.51% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -107.14% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | 357,521.43% | -- | -- |
| Repurchase of Common Stock | -- | -- | -256.65% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -75,633.33% | -3,566.67% | -- | -- | -- |
| Cash from Financing | 16,217.50% | 3,485.89% | 7,251.04% | 0.74% | -9.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 557.47% | 139.38% | 279.50% | 40.61% | 19.55% |